[Clinical experience in long-term testing of Clenbuterol].
D000318:Adrenergic beta-Agonists / Q000009:adverse effects / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000814:Aniline Compounds / Q000009:adverse effects / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy*; D001991:Bronchitis / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004983:Ethanolamines / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008134:Long-Term Care; D008297:Male; D008875:Middle Aged
D000318:Adrenergic beta-Agonists; D000814:Aniline Compounds; D004983:Ethanolamines
Klinische Erfahrungen bei der Langzeitprüfung von Clenbuterol